FDA Inspection 1252129 — Carsgen Therapeutics Corporation
The FDA completed an inspection of Carsgen Therapeutics Corporation on Sep 6, 2024 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 6, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Durham, NC (United States)